Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 223-289-7 | CAS number: 3811-04-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
In cases where data for potassium chlorate were not available or to support data that were found for potassium chlorate, tests performed with sodium chlorate were used in this dossier. Read across is possible for these two substances, because the toxicity of the test substance is expected to be related to the chlorate ion and not by the sodium or potassium ion.
No data available for potassium chlorate. Cross reading to valid animal studies with sodium chlorate do not indicate sensitising properties: Guinea Pig Maximisation test, OECD 406, 2003, K, RS.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Justification for type of information:
- See the RAAF document.
- Reason / purpose for cross-reference:
- read-across: supporting information
- Reason / purpose for cross-reference:
- read-across source
- Positive control results:
- According to the magnusson and Kligman method, positive control test item Mercaptobenzothiazole at the concentration of 20% (w/w) induced positive skin sensitization reactions in 80% (8/10) guinea pigs.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 25% (w/w)
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- 2 animals: dryness
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 25% (w/w). No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: 2 animals: dryness.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 25% (w/w)
- No. with + reactions:
- 1
- Total no. in group:
- 20
- Clinical observations:
- 4 animals: dryness. Remark: motivation for 1 '+' animals see table below.
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 25% (w/w). No with. + reactions: 1.0. Total no. in groups: 20.0. Clinical observations: 4 animals: dryness. Remark: motivation for 1 '+' animals see table below..
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 25% (w/w)
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 25% (w/w). No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 25% (w/w)
- No. with + reactions:
- 2
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 25% (w/w). No with. + reactions: 2.0. Total no. in groups: 10.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 25% (w/w)
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 25% (w/w)
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 10% (w/w)
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 24.0. Group: test group. Dose level: 10% (w/w). No with. + reactions: 0.0. Total no. in groups: 20.0.
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 10% (w/w)
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 48.0. Group: test group. Dose level: 10% (w/w). No with. + reactions: 0.0. Total no. in groups: 20.0.
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 10% (w/w)
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 24.0. Group: negative control. Dose level: 10% (w/w). No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 10% (w/w)
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 48.0. Group: negative control. Dose level: 10% (w/w). No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 10% (w/w)
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 10% (w/w)
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- At 24 h respectively 48 h after rechallenge, neither by the test nor by the control animals, primary skin irritations or a reference to a sensitive effect could be established. The test substance sodium chlorate should not be classified as sensitizing to the skin.
- Executive summary:
A Guinea Pig Maximisation test was conducted with a test group of 20 Hartley guinea pigs and a negative control group of 10 Hartley guinea pigs. They were used to investigate the skin sensitising properties of the test compound. The study was performed in accordance with the method of B. Magnusson and A. M Kligman (OECD-guidelines: Guideline 406 ‘Skin Sensitisation’). The study was designed and performed according to Good Laboratory Practice Standards.
The test group received first intradermal injections with 1% test substance. After 7 days a topical application of SLS in vaseline was performed. Ans on Day 8 the animals were treated with a 48 h occluded epicutaneous applications of 25% (w/w) in 0.9% NaCl. Two weeks after the last application, the test animals received a similar 24 h epicutaneous application. After 24 h and 48 h skin reactions were scored. Controls were treated with vehicle during induction and 25% (w/w) during challenge.
No systemic clinical signs and no deaths were noted during the study.
After the first challenge application, a discrete erythema was recorded in 2/10 animals of the control group at the 48-hour reading. According to the study report a discrete or moderate erythema was noted on one or two flanks of 5/20 animals of the treated group, at the 24 and/or 48-hour readings. However, as the control group shows positive skin reactions, the actual positive skin reaction count is 1/20 animals in the treated group. After rechallenge, no cutaneous reactions were observed.
At 24 h respectively 48 h after rechallenge, neither by the test nor by the control animals, primary skin irritations or a reference to a sensitive effect could be established. The test substance sodium chlorate should not be classified as sensitizing to the skin.
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- January 2003 - April 2003
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study performed according to standard protocols and under GLP.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- The study was performed before the LLNA became the default testing requirement
- Species:
- guinea pig
- Strain:
- Hartley
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories, L'Arbresle, France
- Age at study initiation: on day 1 the animals of the main test were 1-2 months old
- Weight at study initiation: on day 1 (weight±SD): males 391±20 g, females 383±17 g
- Housing: housed individually in polycarbonate cages with stainless steel lid equipped with a polypropylene bottle
- Diet (e.g. ad libitum): 106 pelleted diet (UAR, Villemoisson, Epinay-sur-Orge, France), free access
- Water (e.g. ad libitum): ad lib
- Acclimation period: at least 5 days before the beginning of the study
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22±2
- Humidity (%): 30 - 70
- Air changes (per hr): approximately 12 cycles/hour of filtered, non-recycled air
- Photoperiod (hrs dark / hrs light): 12h/12h
IN-LIFE DATES: From: ? To: ? - Route:
- epicutaneous, occlusive
- Vehicle:
- physiological saline
- Concentration / amount:
- Induction: 25% (w/w)
Challenge: 25% (w/w)
Rechallenge: 10% (w/w) - Route:
- epicutaneous, occlusive
- Vehicle:
- physiological saline
- Concentration / amount:
- Induction: 25% (w/w)
Challenge: 25% (w/w)
Rechallenge: 10% (w/w) - No. of animals per dose:
- - Main test: 30 animals (15 males and 15 females)
In control group: 10 animals (5 males and 5 females)
In treated group: 20 animals (10 males and 10 females)
- Preliminary test: 3 males and 3 females - Details on study design:
- RANGE FINDING TESTS:
- By intradermal route tested concentrations: 25%, 10%, 5%, 1% and 0.1% (w/w) (0.1 mL injected).
- By cutaneous route: Induction phase tested concentration: 25% (w/w) and Challenge phase tested concentrations: 25% and 10% (w/w)
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures:
Intradermal injection: Based on the results of a preliminary study. Six injections were made deep into the dermis of a 4 cm x 2 cm clipped interscapular area, on day 1. Three injections of 0.1 mL were made into each side of this interscapular region (i.e. three pairs of sites), as follows:
1 Anterior
FCA at 50% (v/v) in 0.9% NaCl (Treated group)
FCA at 50% (v/v) in 0.9% NaCl (Control group)
2 Middle
test item at 1% (w/w) in 0.9% NaCl (Treated group)
0.9% NaCl (Control group)
3 Posterior*
test item at 1% (w/w) in the mixture FCA/0.9% NaCl (50/50) (Treated group)
vehicle at 50% (w/v) in a mixture FCA/0.9% NaCl (50/50) (Control group)
Topical application: On day 8, a pad of filter paper (approximately 8 cm2) was fully-loaded with the test item at the concentration of 25% (w/w) and was then applied to the interscapular region of the animals of the treated group. The control group was exposed to the vehicle.
- Exposure period: topical application 48 h
- Test groups: test compound
- Control group: vehicle (NaCl)
- Site: Interscapular region
- Frequency of applications: 7 days after the intradermal injection the sites were treated with the test sample for 48 h
- Duration: from injection till topical applacation was 7 days
- Concentrations: 1% intracutaneous and 25% occlusive epicutaneous
B. CHALLENGE EXPOSURE
- No. of exposures:
Topical application: On day 22, all animals of both groups were challenged by a cutaneous application of the test item to the right flank. The test item was maintained under an occlusive dressing for 24 hours. The vehicle was applied to the left flank under the same experimental conditions.
- Day(s) of challenge: 24 h (3 weeks after the first intradermal injection)
- Exposure period: 24 h
- Test groups: test compound
- Control group: test compound
- Site: posterior flank
- Concentrations: 25 % occlusive epicutaneous (25% (w/w) in 0.9% NaCl)
- Evaluation (hr after challenge): evaluated approximately 24 and 48 hours after removal of the dressing
Grading system:
- no visible change 0
- discrete or patchy erythema 1
- moderate and confluent erythema 2
- intense erythema 3
OTHER: C. RECHALLENGE
As equivocal cutaneous reactions were noted, a second challenge application was performed on day 36. The test item at the concentration of 10% (w/w) in 0.9% NaCl was applied to the left flank and the vehicle to the right flank of animals of both groups, under the same experimental conditions as for the first challenge application. - Challenge controls:
- Yes, treated with test substance.
- Positive control substance(s):
- yes
- Remarks:
- Mercaptobenzothiazole at the concentration of 20% (w/w).
- Positive control results:
- According to the magnusson and Kligman method, positive control test item Mercaptobenzothiazole at the concentration of 20% (w/w) induced positive skin sensitization reactions in 80% (8/10) guinea pigs.
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 25% (w/w)
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- 2 animals: dryness
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 25% (w/w). No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: 2 animals: dryness.
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 25% (w/w)
- No. with + reactions:
- 1
- Total no. in group:
- 20
- Clinical observations:
- 4 animals: dryness. Remark: motivation for 1 '+' animals see table below.
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 25% (w/w). No with. + reactions: 1.0. Total no. in groups: 20.0. Clinical observations: 4 animals: dryness. Remark: motivation for 1 '+' animals see table below..
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 25% (w/w)
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 25% (w/w). No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 25% (w/w)
- No. with + reactions:
- 2
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 25% (w/w). No with. + reactions: 2.0. Total no. in groups: 10.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 25% (w/w)
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 25% (w/w)
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Key result
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 10% (w/w)
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 24.0. Group: test group. Dose level: 10% (w/w). No with. + reactions: 0.0. Total no. in groups: 20.0.
- Key result
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 10% (w/w)
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 48.0. Group: test group. Dose level: 10% (w/w). No with. + reactions: 0.0. Total no. in groups: 20.0.
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 10% (w/w)
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 24.0. Group: negative control. Dose level: 10% (w/w). No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 10% (w/w)
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 48.0. Group: negative control. Dose level: 10% (w/w). No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 10% (w/w)
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 10% (w/w)
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- At 24 h respectively 48 h after rechallenge, neither by the test nor by the control animals, primary skin irritations or a reference to a sensitive effect could be established. The test substance sodium chlorate should not be classified as sensitizing to the skin.
- Executive summary:
A Guinea Pig Maximisation test was conducted with a test group of 20 Hartley guinea pigs and a negative control group of 10 Hartley guinea pigs. They were used to investigate the skin sensitising properties of the test compound. The study was performed in accordance with the method of B. Magnusson and A. M Kligman (OECD-guidelines: Guideline 406 ‘Skin Sensitisation’). The study was designed and performed according to Good Laboratory Practice Standards.
The test group received first intradermal injections with 1% test substance. After 7 days a topical application of SLS in vaseline was performed. And on Day 8 the animals were treated with a 48 h occluded epicutaneous applications of 25% (w/w) in 0.9% NaCl. Two weeks after the last application, the test animals received a similar 24 h epicutaneous application. After 24 h and 48 h skin reactions were scored. Controls were treated with vehicle during induction and 25% (w/w) during challenge.
No systemic clinical signs and no deaths were noted during the study.
After the first challenge application, a discrete erythema was recorded in 2/10 animals of the control group at the 48-hour reading. According to the study report a discrete or moderate erythema was noted on one or two flanks of 5/20 animals of the treated group, at the 24 and/or 48-hour readings. However, as the control group shows positive skin reactions, the actual positive skin reaction count is 1/20 animals in the treated group. After rechallenge, no cutaneous reactions were observed.
At 24 h respectively 48 h after rechallenge, neither by the test nor by the control animals, primary skin irritations or a reference to a sensitive effect could be established. The test substance sodium chlorate should not be classified as sensitizing to the skin.
Referenceopen allclose all
In the control group 2 animals were tested positive. So the animals with a scoring of '1' in the treated group are equivocal and therefore not evaluated as a positive reaction. See table below.
FIRST CHALLENGE |
|||
Scoring at 24h Conc. 25%(w/w) |
Scoring at 48h Conc. 25%(w/w) |
+ or ± or - |
|
Controls |
|||
31 M |
0 |
0 |
- |
32 M |
0 |
0 |
- |
33 M |
0 |
0 |
- |
34 M |
0 |
0 |
- |
35 M |
0 |
0 |
- |
46 F |
0 |
0 |
- |
47 F |
0 |
1 |
- |
48 F |
0 |
0 |
- |
49 F |
0 |
0 |
- |
50 F |
0 |
1 |
- |
Treated group |
|||
36 M |
0 |
0 |
- |
37 M |
0 |
0 |
- |
38 M |
0 |
0 |
- |
39 M |
0 |
0 |
- |
40 M |
0 |
1 |
± |
41 M |
1/S |
2/S |
+ |
42 M |
0 |
0 |
- |
43 M |
0 |
0 |
- |
44 M |
0 |
0 |
- |
45 M |
1 |
1/S |
± |
51 F |
0 |
0 |
- |
52 F |
0 |
0 |
- |
53 F |
0 |
0 |
- |
54 F |
0 |
0 |
- |
55 F |
0 |
0 |
- |
56 F |
1/S |
0/S |
± |
57 F |
0 |
0 |
- |
58 F |
0 |
0 |
- |
59 F |
0 |
0 |
- |
60 F |
0 |
0/S |
? |
S = dryness of the skin
In the control group 2 animals were tested positive. So the animals with a scoring of '1' in the treated group are equivocal and therefore not evaluated as a positive reaction. See table below.
FIRST CHALLENGE |
|||
Scoring at 24h Conc. 25%(w/w) |
Scoring at 48h Conc. 25%(w/w) |
+ or ± or - |
|
Controls |
|||
31 M |
0 |
0 |
- |
32 M |
0 |
0 |
- |
33 M |
0 |
0 |
- |
34 M |
0 |
0 |
- |
35 M |
0 |
0 |
- |
46 F |
0 |
0 |
- |
47 F |
0 |
1 |
- |
48 F |
0 |
0 |
- |
49 F |
0 |
0 |
- |
50 F |
0 |
1 |
- |
Treated group |
|||
36 M |
0 |
0 |
- |
37 M |
0 |
0 |
- |
38 M |
0 |
0 |
- |
39 M |
0 |
0 |
- |
40 M |
0 |
1 |
± |
41 M |
1/S |
2/S |
+ |
42 M |
0 |
0 |
- |
43 M |
0 |
0 |
- |
44 M |
0 |
0 |
- |
45 M |
1 |
1/S |
± |
51 F |
0 |
0 |
- |
52 F |
0 |
0 |
- |
53 F |
0 |
0 |
- |
54 F |
0 |
0 |
- |
55 F |
0 |
0 |
- |
56 F |
1/S |
0/S |
± |
57 F |
0 |
0 |
- |
58 F |
0 |
0 |
- |
59 F |
0 |
0 |
- |
60 F |
0 |
0/S |
? |
S = dryness of the skin
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
In view of the lack of reported sensitization in humans in literature despite years of use, the overall evaluation is that there seems to be no concern for sensitizing properties for potassium chlorate.
A key study on Sodium Chlorate was identified (GPMT, Manciaux, Centre International de toxicologie, 2003, RS, rel.1).
A Guinea Pig Maximisation test was conducted with a test group of 20 Hartley guinea pigs and a negative control group of 10 Hartley guinea pigs. They were used to investigate the skin sensitising properties of the test compound. The study was performed in accordance with the method of B. Magnusson and A. M Kligman (OECD-guidelines: Guideline 406 ‘Skin Sensitisation’). The study was designed and performed according to Good Laboratory Practice Standards.
The test group received first intradermal injections with 1% test substance. After 7 days a topical application of SLS in vaseline was performed. Ans on Day 8 the animals were treated with a 48 h occluded epicutaneous applications of 25% (w/w) in 0.9% NaCl. Two weeks after the last application, the test animals received a similar 24 h epicutaneous application. After 24 h and 48 h skin reactions were scored. Controls were treated with vehicle during induction and 25% (w/w) during challenge.
No systemic clinical signs and no deaths were noted during the study.
After the first challenge application, a discrete erythema was recorded in 2/10 animals of the control group at the 48-hour reading. According to the study report a discrete or moderate erythema was noted on one or two flanks of 5/20 animals of the treated group, at the 24 and/or 48-hour readings. However, as the control group shows positive skin reactions, the actual positive skin reaction count is 1/20 animals in the treated group. After rechallenge, no cutaneous reactions were observed.
At 24 h respectively 48 h after rechallenge, neither by the test nor by the control animals, primary skin irritations or a reference to a sensitive effect could be established.
The test substance sodium chlorate should not be classified as sensitizing to the skin.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
- Additional information:
No data available.
Justification for classification or non-classification
Harmonised classification:
The substance has no harmonised classification according to the Regulation (EC) No. 1272/2008 (CLP).
Self classification:
Available data and studies do not indicate that sodium chlorate has a potential for skin sensitisation. These data are used to fill the endpoint for potassium chlorate. Potassium chlorate is not classified as a sensitiser.
No data was available for respiratory sensitisation. However, this substance is not a skin sensitiser, therefore according to Figure R.7.3–4. Assessment strategy for respiratory sensitisation data of the Chapter R.7a (Version 6.0 – July 2017) the chemical is not considered as a respiratory sensitiser.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.